Avanos Medical's profits and revenue both exceeded expectations

LootboxPhobia · 2026-02-24T15:36:29+00:00

Avanos Medical announces Q4 results, with adjusted EPS of $0.29 exceeding expectations, and revenue of $180.9 million, up 0.7% year-over-year. The company is optimistic about future growth, expecting FY2026 revenue to reach $700 million to $720 million, and will continue to advance its transformation initiatives.

LootboxPhobia

2026-02-24 15:36:29

Abstract generation in progress

Georgia, Alpharetta - Avanos Medical, Inc. (NYSE:AVNS) reported Q4 earnings that exceeded analyst expectations in both profit and revenue.

The company’s stock remained flat in after-hours trading.

The medical device company’s adjusted Q4 earnings per share were $0.29, beating the consensus estimate of $0.25 by $0.04.

Revenue reached $180.9 million, surpassing the $169 million forecast, a 0.7% increase from the same period last year. The company’s Specialty Nutrition Systems division drove growth, with sales of $115.1 million, up 8.7% year-over-year, while the Pain Management and Recovery division saw revenue grow 1.3% to $61.6 million.

Avanos CEO David Pacitti said, “I am very pleased with our Q4 and full-year performance, which demonstrates meaningful progress in our strategic priorities. Our organic growth remains healthy, laying a solid foundation for 2026.”

For fiscal 2026, Avanos issued guidance of $0.90 to $1.10 per share, with a midpoint of $1.00, in line with analyst expectations. The company expects revenue between $700 million and $720 million.

For the full fiscal year 2025, Avanos reported net sales of $701.2 million, a 1.9% increase from 2024, with adjusted diluted earnings per share of $0.94.

The company recorded a GAAP diluted loss per share of $1.57, mainly due to a $77 million goodwill impairment charge in Q2. Free cash flow for 2025 totaled $43.1 million, down from $82.9 million last year.

The company announced an expansion of its transformation initiatives, expecting to generate an incremental annual savings of $15 million to $20 million by the end of 2026.

This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.